The opportunity within the cytotoxic drugs and HPAPI manufacturing market is projected to grow at an annualized rate of ~12%, till 2035, claims Roots Analysis London, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cytotoxic Drugs and HPAPI Manufacturing Market (4th Edition), 2022 – 2035” report to its list of offerings. ...

Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform Results Indicate Induction of Adaptive Immune Response Against SARS-CoV-2 Company Plans Additional Development Work to Further Optimize its Vaccine Platform Through Vector Compositions, Delivery...

Closed Drug Transfer Systems - Therapeutic Markets, Strategies and Outlook Dublin, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/x53tf3/closed_drug) has announced the addition of the "Closed Drug Transfer Systems....

Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011 PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...